MCCANN JOE A. (Chief Executive Officer) reported 1 transaction at POINT BIOPHARMA GLOBAL INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/7/2023ACC: 0001104659-23-115375
DirectorOfficer· Chief Executive Officer
Since Jun 2021
-120K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
120K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−120K
Price / share
—
Trade value
—
% of position
3.3%
11/6/2023
3.61M→3.49M
Total
Net shares
−120K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/6/2023 | G · Gift | −120K | — | — | 3.3% | 3.61M | 3.49M |
| Total | −120K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned2.16K
Total
2.16K direct2.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.16K | Direct |
| Total | 2.16K | 2.16K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported